Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
Business

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link

Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
Business

Amgen's Deal for Horizon Therapeutics Clears Key Hurdle

The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims

FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
Business

FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics

The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link

Biogen to Buy Reata in $7.3 Billion Deal
Business

Biogen to Buy Reata in $7.3 Billion Deal

The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link

Big Pharma Bets Big on China
Business

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Business

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Finances

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link

Obesity Drugs Won't Starve These Other Potential Blockbusters
Finances

Obesity Drugs Won't Starve These Other Potential Blockbusters

Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link

Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Finances

Merck in Late-Stage Talks to Acquire Prometheus Biosciences

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the